Skip to main content

Devyser Signs Chinese Distribution Deal for Prenatal Aneuploidy Tests

NEW YORK (GenomeWeb) – Swedish diagnostic company Devyser has signed a distribution deal for its rapid prenatal aneuploidy diagnostic test kits in China with Dahui Biotech, the companies announced today.

Specific terms of the deal were not disclosed.

"There is an increasing demand for our prenatal diagnostic products in China," Devyser Founding Partner and CEO Ulf Klangby said in a statement. "Dahui Biotech's established distribution and service organization reaches genetic laboratories across China."

Devyser offers a range of PCR-based tests including Compact QF-PCR, which enables prenatal aneuploidy analysis of chromosomes 13, 18, 21, and XY; Extend QF-PCR for pregnancy loss aneuploidy analysis covering chromosomes 13, 15, 16, 18, 21, 22, and XY; and Complete QF-PCR for rapid aneuploidy analysis of chromosomes 13, 18, 21, and XY.